275 related articles for article (PubMed ID: 19556043)
41. Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.
Rossing P; Block GA; Chin MP; Goldsberry A; Heerspink HJL; McCullough PA; Meyer CJ; Packham D; Pergola PE; Spinowitz B; Sprague SM; Warnock DG; Chertow GM
Kidney Int; 2019 Oct; 96(4):1030-1036. PubMed ID: 31377056
[TBL] [Abstract][Full Text] [Related]
42. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
43. Spot urinary protein/osmolality ratio as a predictor for proteinuria of nephrotic range.
Jahan S; Islam MS; Hossain MM
Bangladesh Med Res Counc Bull; 2007 Aug; 33(2):65-8. PubMed ID: 18481441
[TBL] [Abstract][Full Text] [Related]
44. Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy.
Friedman AN; Hunsicker LG; Selhub J; Bostom AG;
Diabetes Care; 2002 Nov; 25(11):2037-41. PubMed ID: 12401753
[TBL] [Abstract][Full Text] [Related]
45. Effect of postural change on urine volume and urinary sodium excretion in diabetic nephropathy.
Ogi M; Kojima S; Kuramochi M
Am J Kidney Dis; 1998 Jan; 31(1):41-8. PubMed ID: 9428450
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathological features of diabetic and nondiabetic renal diseases in type 2 diabetic patients with nephrotic-range proteinuria.
Lee YH; Kim KP; Kim YG; Moon JY; Jung SW; Park E; Kim JS; Jeong KH; Lee TW; Ihm CG; Jo YI; Choi HY; Park HC; Lee SY; Yang DH; Yi JH; Han SW; Lee SH
Medicine (Baltimore); 2017 Sep; 96(36):e8047. PubMed ID: 28885376
[TBL] [Abstract][Full Text] [Related]
47. Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine Ratio.
Herrington W; Illingworth N; Staplin N; Kumar A; Storey B; Hrusecka R; Judge P; Mahmood M; Parish S; Landray M; Haynes R; Baigent C; Hill M; Clark S
Clin J Am Soc Nephrol; 2016 Oct; 11(10):1794-1801. PubMed ID: 27654930
[TBL] [Abstract][Full Text] [Related]
48. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
[TBL] [Abstract][Full Text] [Related]
49. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.
Chiarelli F; Verrotti A; Mohn A; Morgese G
Ann Med; 1997 Oct; 29(5):439-45. PubMed ID: 9453292
[TBL] [Abstract][Full Text] [Related]
50. Urine albumin creatinine ratio and clinical correlates in a diabetic population.
Woolerton J; Jury DR; Dunn PJ; Speed JF
N Z Med J; 1987 Mar; 100(819):130-4. PubMed ID: 3452021
[TBL] [Abstract][Full Text] [Related]
51. Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy.
Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; Pisano L; D'Amico G
Am J Kidney Dis; 2001 Aug; 38(2):240-8. PubMed ID: 11479148
[TBL] [Abstract][Full Text] [Related]
52. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
53. Quantitation of proteinuria using protein-creatinine ratio in random urine samples.
Iyer RS; Shailaja SN; Bhaskaranand N; Baliga M; Venkatesh A
Indian Pediatr; 1991 May; 28(5):463-7. PubMed ID: 1752671
[TBL] [Abstract][Full Text] [Related]
54. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
Yamanouchi M; Furuichi K; Hoshino J; Toyama T; Hara A; Shimizu M; Kinowaki K; Fujii T; Ohashi K; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Mise K; Makino H; Matsuo S; Ubara Y; Wada T;
Diabetes Care; 2019 May; 42(5):891-902. PubMed ID: 30833372
[TBL] [Abstract][Full Text] [Related]
55. Diagnosis and management of nephrotic syndrome.
McCloskey O; Maxwell AP
Practitioner; 2017 Feb; 261(1801):11-5. PubMed ID: 29020719
[TBL] [Abstract][Full Text] [Related]
56. Effect of urine urea nitrogen and protein intake adjusted by using the estimated urine creatinine excretion rate on the antiproteinuric effect of angiotensin II type I receptor blockers.
Chin HJ; Kim DK; Park JH; Shin SJ; Lee SH; Choi BS; Kim S; Lim CS
Nutrition; 2015; 31(11-12):1333-8. PubMed ID: 26304595
[TBL] [Abstract][Full Text] [Related]
57. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
Wilmer WA; Hebert LA; Lewis EJ; Rohde RD; Whittier F; Cattran D; Levey AS; Lewis JB; Spitalewitz S; Blumenthal S; Bain RP
Am J Kidney Dis; 1999 Aug; 34(2):308-14. PubMed ID: 10430979
[TBL] [Abstract][Full Text] [Related]
58. The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group.
Rodby RA; Rohde RD; Clarke WR; Hunsicker LG; Anzalone DA; Atkins RC; Ritz E; Lewis EJ
Nephrol Dial Transplant; 2000 Apr; 15(4):487-97. PubMed ID: 10727543
[TBL] [Abstract][Full Text] [Related]
59. Assessing albuminuria in spot morning samples from diabetic patients.
Sampaio E; Delfino VD
Arq Bras Endocrinol Metabol; 2008 Dec; 52(9):1482-8. PubMed ID: 19197457
[TBL] [Abstract][Full Text] [Related]
60. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design.
Shikata K; Haneda M; Koya D; Suzuki Y; Tomino Y; Yamada K; Maeda S; Kawakami N; Uzu T; Nishimura M; Sato C; Ogawa D; Makino H;
Diabetes Res Clin Pract; 2010 Feb; 87(2):228-32. PubMed ID: 19889469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
